MARRONE BIO INNOVATIONS INC.
CIK 0001441693
Revenue (TTM)
$44.59M
+15.5% YoY
Q1 May 2022
Net Income (TTM)
−$18.84M
+17.9% YoY
Q1 May 2022
EPS Diluted (TTM)
−$14.64
−171.2% YoY
Q1 May 2022
Gross Margin
60.5%
Q1 May 2022
Operating Margin
-37.7%
Q1 May 2022
Net Margin
-42.2%
Q1 May 2022
Free Cash Flow (TTM)
−$27.92M
Q1 May 2022
Cash
$9.36M
Q1 May 2022
Total Debt
$31.87M
Q1 May 2022
Shares Outstanding
182.34M sh
Q1 May 2022